Published

Verbal behavior related to drug reinforcement in polysubstance cannabis users: Comparison across drugs.

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: Experimental and clinical psychopharmacology
Date: 2022-04-01
Source: PubMed
DOI: 10.1037/pha0000404
PubMed: 34291991

Authors

Cox DJ Johnson MW

Watch author

Derived topics and classifications

psilocybin Addiction Pharmacology Healthcare Workers Other

Citation graph

0 referenced DOIs found in stored source metadata. 0 indexed papers cite this DOI.

Open citation network

Related papers

Medical Uses and Adverse Effects of Psilocybin.The primary care companion for CNS disorders · 2024-05-28 Exposure to Potent Hallucinogens in an AdolescentThe Primary Care Companion For CNS Disorders · 2013-10-23 Feasibility Phase 2 Study of Psilocybin-Assisted Therapy for Opioid-Refractory Pain in Patients With Advanced CancerClinicalTrials.gov · 2026-08-05 Safety and Feasibility of Psilocybin in Methamphetamine Use Disorder in a Community-Based SampleClinicalTrials.gov · 2026-05-12 Strategic Neurodelivery of Psychedelic Compounds: Bridging Molecular Pharmacology with Therapeutic Innovation in CNS Disorders.CNS & neurological disorders drug targets · 2026-03-11 With great power comes great responsibility: Promise and caution in the new psychedelic renaissanceBrain Disorders · 2025-09-23 Psilocybin and the Development of Serotonin Toxicity.The primary care companion for CNS disorders · 2024-02-29 Modern Psychedelic Microdosing Research on Mental Health: A Systematic Review.The primary care companion for CNS disorders · 2024-01-16